| Bangladesh | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 106.2 (2020) [164/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 1.2 (2020) [168/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 0.9 (2020) [159/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 17.0 (2020) [181/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 10.6 (2020) [121/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 3.4 (2020) [157/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 1.5 (2020) [175/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 4.9 (2020) [3/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 1.1 (2020) [154/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 3.7 (2020) [16/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 1.8 (2020) [162/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 9.5 (2020) [5/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 2.2 (2020) [180/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 9.5 (2020) [108/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 1.0 (2020) [175/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 0.6 (2020) [148/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.6 (2020) [58/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 2.6 (2020) [170/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 14.8 (2020) [3/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 2.6 (2020) [12/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 3.9 (2020) [152/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 1.0 (2020) [170/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 3.6 (2020) [180/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 5.2 (2020) [100/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.5 (2020) [129/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 1.0 (2020) [158/184countries] | | |
|
| Bangladesh | | |
Suicide, age-standardized (per 100 000 population) | 3.85 (2019) [153/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 6.02 (2019) [151/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 1.66 (2019) [156/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 4.28 (2019) [114/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 5.58 (2019) [124/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 2.94 (2019) [76/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 4.41 (2019) [150/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 7.18 (2019) [143/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 1.68 (2019) [152/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 4.26 (2019) [160/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 6.72 (2019) [155/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 1.85 (2019) [151/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 5.25 (2019) [152/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 8.26 (2019) [150/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 2.13 (2019) [147/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 4.92 (2019) [154/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 7.88 (2019) [154/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 1.65 (2019) [154/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 6.36 (2019) [148/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 10.22 (2019) [148/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 2.16 (2019) [155/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 10.27 (2019) [133/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 17.80 (2019) [130/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 3.05 (2019) [150/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 19.53 (2019) [120/183countries] | | |
|
|